Recent developments in the management of invasive fungal infections in patients with hematological malignancies
- 22 December 2004
- journal article
- review article
- Published by Springer Nature in Annals of Hematology
- Vol. 84 (4) , 207-216
- https://doi.org/10.1007/s00277-004-0986-0
Abstract
Despite recent advances in the last decade, invasive fungal infections are still associated with a high morbidity and mortality. Invasive fungal infections constitute severe infectious complications in patients with hematological malignancies receiving myelosuppressive chemotherapy or sustained immunosuppression after allogeneic transplant regimens. Following a long period of stagnation, considerable progress has been made during the last 5 years in non-culture-based diagnostics and in the treatment of invasive fungal infections. This review highlights recent developments in the epidemiology, diagnosis, and treatment in the context of state-of-the-art management of invasive fungal infections in cancer patients.Keywords
This publication has 28 references indexed in Scilit:
- Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignanciesBlood, 2003
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Antifungal prophylaxis for severely neutropenic chemotherapy recipientsCancer, 2002
- Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary InvestigatorsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial TherapyAnnals of Internal Medicine, 2001
- Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropeniaBritish Journal of Haematology, 2000
- International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal InfectionsClinical Infectious Diseases, 1997